Analyst Explains Why He’s Investing in This Top Biotech ETF
“But this is a subsector that’s been under the mat for quite some time. So it’s nice to see some price action there. So couple things for me.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 830,100 | $157,876,719 | +34488% | 0.32% | |
| 2. | Bronte Capital John Hempton | 65,807 | $12,515,833 | -5% | 1.34% |
| 3. | Quantinno Capital Hoon Kim | 22,223 | $4,226,700 | +12% | 0.01% |
| 4. | Renaissance Technologies Jim Simons | 22,100 | $4,203,199 | +257% | 0.01% |
| 5. | Dorset Management David M. Knott | 5,500 | $1,046,045 | 0.55% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,760,709 | $905,439,324 | 0.3% | |
| 2. | 3,320,977 | $631,616,841 | 0.03% | |
| 3. | 2,217,939 | $421,829,818 | 0.15% | |
| 4. | 1,122,659 | $213,518,446 | 0.05% | |
| 5. | 909,315 | $172,942,620 | 0.76% |